Harcharan Gill
Key Documents
Contact Information
-
Clinical Offices
Uro-Oncology Clinic 875 Blake Wilbur Dr Clinic E Stanford, CA 94305-5826 Tel Work (650) 725-5544 Fax (650) 723-0765
- Academic Offices
Personal Information Email Tel (650) 725-5544Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Urologic Oncology
- Bladder Cancer - Urologic Oncology
- Bladder Cancer
- Kidney Cancer
- Penile Cancer
Administrative Appointments
- Clerkship Director, Urology (1998 - 2005)
- Program Director, Residency program (2006 - present)
Professional Education
| Board Certification: | Urology, American Board of Urology (1995) |
| Fellowship: | University of Pennsylvania School of Medicine PA (1991) |
| Residency: | Institute Of Urology, England (1987) |
| Residency: | Royal College of Ireland, Ireland (1982) |
| Internship: | Kenyatta National Hosp. (1978) |
Internet Links
Scientific Focus
Current Research Interests
Benign Prostatic Hyperplasia- Evaluation of new minimally invasive techniques. HIFU and cryotherapy are being evaluated as a image guided minimally invasive technique for the treatment of symptomatic BPH
Clinical Trials
- Microarray Analysis of Gene Expression in Prostate Tissues Recruiting
- Prostate Active Surveillance Study (PASS) Recruiting
- Quality of Life Following Radical Prostatectomy Recruiting
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Completed
- Hypofractionated Radiotherapy for Localized Prostate Cancer (with CyberKnife or with IMRT) Completed
Publications
- MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2011; (10): 1427-30
- Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011; (1): 82-8
- Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC). Urol Oncol. 2011
- Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A. 2009; (33): 14016-21
- Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. J Urol. 2009; (6): 2748-52
